Opinions Samuel D. Isaly
OSI Pharmaceuticals Inc.OSIPTOP PICKAug 13, 2004
Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.
Samuel D. IsalyOwned
$53.71
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
